For the second year in a row, and just as the fiscal 2024 National Defense Authorization Act process peaks in Congress, the Biden administration’s Defense Department seeks executive branch authority to spend U.S. taxpayer Defense Production Act money with foreign suppliers, in addition to American ones.
Last year, Congress rejected the proposal, and it would be wise to do so again.
For medical…
